Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Inguinal Hernia Market

ID: MRFR/HC/3009-HCR
200 Pages
Vikita Thakur
Last Updated: April 06, 2026

Global Inguinal Hernia Market Research Report By Surgical Method (Open Surgery, Laparoscopic Surgery, Robotic-Assisted Surgery), By Type of Hernia (Direct Inguinal Hernia, Indirect Inguinal Hernia), By Material Used (Synthetic Mesh, Biological Mesh, Absorbable Mesh), By End Use (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) -Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Inguinal Hernia Market Infographic
Purchase Options
  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Healthcare, BY Surgical Method (USD Billion) | |
      1. 4.1.1 Open Surgery | |
      2. 4.1.2 Laparoscopic Surgery | |
      3. 4.1.3 Robotic-Assisted Surgery |
    2. 4.2 Healthcare, BY Type of Hernia (USD Billion) | |
      1. 4.2.1 Direct Inguinal Hernia | |
      2. 4.2.2 Indirect Inguinal Hernia |
    3. 4.3 Healthcare, BY Material Used (USD Billion) | |
      1. 4.3.1 Synthetic Mesh | |
      2. 4.3.2 Biological Mesh | |
      3. 4.3.3 Absorbable Mesh |
    4. 4.4 Healthcare, BY End-Use (USD Billion) | |
      1. 4.4.1 Hospitals | |
      2. 4.4.2 Ambulatory Surgical Centers | |
      3. 4.4.3 Specialty Clinics |
    5. 4.5 Healthcare, BY Region (USD Billion) | |
      1. 4.5.1 North America | | |
        1. 4.5.1.1 US | | |
        2. 4.5.1.2 Canada | |
      2. 4.5.2 Europe | | |
        1. 4.5.2.1 Germany | | |
        2. 4.5.2.2 UK | | |
        3. 4.5.2.3 France | | |
        4. 4.5.2.4 Russia | | |
        5. 4.5.2.5 Italy | | |
        6. 4.5.2.6 Spain | | |
        7. 4.5.2.7 Rest of Europe | |
      3. 4.5.3 APAC | | |
        1. 4.5.3.1 China | | |
        2. 4.5.3.2 India | | |
        3. 4.5.3.3 Japan | | |
        4. 4.5.3.4 South Korea | | |
        5. 4.5.3.5 Malaysia | | |
        6. 4.5.3.6 Thailand | | |
        7. 4.5.3.7 Indonesia | | |
        8. 4.5.3.8 Rest of APAC | |
      4. 4.5.4 South America | | |
        1. 4.5.4.1 Brazil | | |
        2. 4.5.4.2 Mexico | | |
        3. 4.5.4.3 Argentina | | |
        4. 4.5.4.4 Rest of South America | |
      5. 4.5.5 MEA | | |
        1. 4.5.5.1 GCC Countries | | |
        2. 4.5.5.2 South Africa | | |
        3. 4.5.5.3 Rest of MEA 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Healthcare | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 Ethicon (US) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 Medtronic (US) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 Bard (US) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 Surgical Innovations (GB) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 Stryker (US) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 B. Braun (DE) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Cook Medical (US) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 Olympus (JP) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies | |
      9. 5.2.9 Conmed (US) | | |
        1. 5.2.9.1 Financial Overview | | |
        2. 5.2.9.2 Products Offered | | |
        3. 5.2.9.3 Key Developments | | |
        4. 5.2.9.4 SWOT Analysis | | |
        5. 5.2.9.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 NORTH AMERICA MARKET ANALYSIS |
    6. 6.3 US MARKET ANALYSIS BY SURGICAL METHOD |
    7. 6.4 US MARKET ANALYSIS BY TYPE OF HERNIA |
    8. 6.5 US MARKET ANALYSIS BY MATERIAL USED |
    9. 6.6 US MARKET ANALYSIS BY END-USE |
    10. 6.7 CANADA MARKET ANALYSIS BY SURGICAL METHOD |
    11. 6.8 CANADA MARKET ANALYSIS BY TYPE OF HERNIA |
    12. 6.9 CANADA MARKET ANALYSIS BY MATERIAL USED |
    13. 6.10 CANADA MARKET ANALYSIS BY END-USE |
    14. 6.11 EUROPE MARKET ANALYSIS |
    15. 6.12 GERMANY MARKET ANALYSIS BY SURGICAL METHOD |
    16. 6.13 GERMANY MARKET ANALYSIS BY TYPE OF HERNIA |
    17. 6.14 GERMANY MARKET ANALYSIS BY MATERIAL USED |
    18. 6.15 GERMANY MARKET ANALYSIS BY END-USE |
    19. 6.16 UK MARKET ANALYSIS BY SURGICAL METHOD |
    20. 6.17 UK MARKET ANALYSIS BY TYPE OF HERNIA |
    21. 6.18 UK MARKET ANALYSIS BY MATERIAL USED |
    22. 6.19 UK MARKET ANALYSIS BY END-USE |
    23. 6.20 FRANCE MARKET ANALYSIS BY SURGICAL METHOD |
    24. 6.21 FRANCE MARKET ANALYSIS BY TYPE OF HERNIA |
    25. 6.22 FRANCE MARKET ANALYSIS BY MATERIAL USED |
    26. 6.23 FRANCE MARKET ANALYSIS BY END-USE |
    27. 6.24 RUSSIA MARKET ANALYSIS BY SURGICAL METHOD |
    28. 6.25 RUSSIA MARKET ANALYSIS BY TYPE OF HERNIA |
    29. 6.26 RUSSIA MARKET ANALYSIS BY MATERIAL USED |
    30. 6.27 RUSSIA MARKET ANALYSIS BY END-USE |
    31. 6.28 ITALY MARKET ANALYSIS BY SURGICAL METHOD |
    32. 6.29 ITALY MARKET ANALYSIS BY TYPE OF HERNIA |
    33. 6.30 ITALY MARKET ANALYSIS BY MATERIAL USED |
    34. 6.31 ITALY MARKET ANALYSIS BY END-USE |
    35. 6.32 SPAIN MARKET ANALYSIS BY SURGICAL METHOD |
    36. 6.33 SPAIN MARKET ANALYSIS BY TYPE OF HERNIA |
    37. 6.34 SPAIN MARKET ANALYSIS BY MATERIAL USED |
    38. 6.35 SPAIN MARKET ANALYSIS BY END-USE |
    39. 6.36 REST OF EUROPE MARKET ANALYSIS BY SURGICAL METHOD |
    40. 6.37 REST OF EUROPE MARKET ANALYSIS BY TYPE OF HERNIA |
    41. 6.38 REST OF EUROPE MARKET ANALYSIS BY MATERIAL USED |
    42. 6.39 REST OF EUROPE MARKET ANALYSIS BY END-USE |
    43. 6.40 APAC MARKET ANALYSIS |
    44. 6.41 CHINA MARKET ANALYSIS BY SURGICAL METHOD |
    45. 6.42 CHINA MARKET ANALYSIS BY TYPE OF HERNIA |
    46. 6.43 CHINA MARKET ANALYSIS BY MATERIAL USED |
    47. 6.44 CHINA MARKET ANALYSIS BY END-USE |
    48. 6.45 INDIA MARKET ANALYSIS BY SURGICAL METHOD |
    49. 6.46 INDIA MARKET ANALYSIS BY TYPE OF HERNIA |
    50. 6.47 INDIA MARKET ANALYSIS BY MATERIAL USED |
    51. 6.48 INDIA MARKET ANALYSIS BY END-USE |
    52. 6.49 JAPAN MARKET ANALYSIS BY SURGICAL METHOD |
    53. 6.50 JAPAN MARKET ANALYSIS BY TYPE OF HERNIA |
    54. 6.51 JAPAN MARKET ANALYSIS BY MATERIAL USED |
    55. 6.52 JAPAN MARKET ANALYSIS BY END-USE |
    56. 6.53 SOUTH KOREA MARKET ANALYSIS BY SURGICAL METHOD |
    57. 6.54 SOUTH KOREA MARKET ANALYSIS BY TYPE OF HERNIA |
    58. 6.55 SOUTH KOREA MARKET ANALYSIS BY MATERIAL USED |
    59. 6.56 SOUTH KOREA MARKET ANALYSIS BY END-USE |
    60. 6.57 MALAYSIA MARKET ANALYSIS BY SURGICAL METHOD |
    61. 6.58 MALAYSIA MARKET ANALYSIS BY TYPE OF HERNIA |
    62. 6.59 MALAYSIA MARKET ANALYSIS BY MATERIAL USED |
    63. 6.60 MALAYSIA MARKET ANALYSIS BY END-USE |
    64. 6.61 THAILAND MARKET ANALYSIS BY SURGICAL METHOD |
    65. 6.62 THAILAND MARKET ANALYSIS BY TYPE OF HERNIA |
    66. 6.63 THAILAND MARKET ANALYSIS BY MATERIAL USED |
    67. 6.64 THAILAND MARKET ANALYSIS BY END-USE |
    68. 6.65 INDONESIA MARKET ANALYSIS BY SURGICAL METHOD |
    69. 6.66 INDONESIA MARKET ANALYSIS BY TYPE OF HERNIA |
    70. 6.67 INDONESIA MARKET ANALYSIS BY MATERIAL USED |
    71. 6.68 INDONESIA MARKET ANALYSIS BY END-USE |
    72. 6.69 REST OF APAC MARKET ANALYSIS BY SURGICAL METHOD |
    73. 6.70 REST OF APAC MARKET ANALYSIS BY TYPE OF HERNIA |
    74. 6.71 REST OF APAC MARKET ANALYSIS BY MATERIAL USED |
    75. 6.72 REST OF APAC MARKET ANALYSIS BY END-USE |
    76. 6.73 SOUTH AMERICA MARKET ANALYSIS |
    77. 6.74 BRAZIL MARKET ANALYSIS BY SURGICAL METHOD |
    78. 6.75 BRAZIL MARKET ANALYSIS BY TYPE OF HERNIA |
    79. 6.76 BRAZIL MARKET ANALYSIS BY MATERIAL USED |
    80. 6.77 BRAZIL MARKET ANALYSIS BY END-USE |
    81. 6.78 MEXICO MARKET ANALYSIS BY SURGICAL METHOD |
    82. 6.79 MEXICO MARKET ANALYSIS BY TYPE OF HERNIA |
    83. 6.80 MEXICO MARKET ANALYSIS BY MATERIAL USED |
    84. 6.81 MEXICO MARKET ANALYSIS BY END-USE |
    85. 6.82 ARGENTINA MARKET ANALYSIS BY SURGICAL METHOD |
    86. 6.83 ARGENTINA MARKET ANALYSIS BY TYPE OF HERNIA |
    87. 6.84 ARGENTINA MARKET ANALYSIS BY MATERIAL USED |
    88. 6.85 ARGENTINA MARKET ANALYSIS BY END-USE |
    89. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY SURGICAL METHOD |
    90. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE OF HERNIA |
    91. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY MATERIAL USED |
    92. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY END-USE |
    93. 6.90 MEA MARKET ANALYSIS |
    94. 6.91 GCC COUNTRIES MARKET ANALYSIS BY SURGICAL METHOD |
    95. 6.92 GCC COUNTRIES MARKET ANALYSIS BY TYPE OF HERNIA |
    96. 6.93 GCC COUNTRIES MARKET ANALYSIS BY MATERIAL USED |
    97. 6.94 GCC COUNTRIES MARKET ANALYSIS BY END-USE |
    98. 6.95 SOUTH AFRICA MARKET ANALYSIS BY SURGICAL METHOD |
    99. 6.96 SOUTH AFRICA MARKET ANALYSIS BY TYPE OF HERNIA |
    100. 6.97 SOUTH AFRICA MARKET ANALYSIS BY MATERIAL USED |
    101. 6.98 SOUTH AFRICA MARKET ANALYSIS BY END-USE |
    102. 6.99 REST OF MEA MARKET ANALYSIS BY SURGICAL METHOD |
    103. 6.100 REST OF MEA MARKET ANALYSIS BY TYPE OF HERNIA |
    104. 6.101 REST OF MEA MARKET ANALYSIS BY MATERIAL USED |
    105. 6.102 REST OF MEA MARKET ANALYSIS BY END-USE |
    106. 6.103 KEY BUYING CRITERIA OF HEALTHCARE |
    107. 6.104 RESEARCH PROCESS OF MRFR |
    108. 6.105 DRO ANALYSIS OF HEALTHCARE |
    109. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
    110. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
    111. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE |
    112. 6.109 HEALTHCARE, BY SURGICAL METHOD, 2024 (% SHARE) |
    113. 6.110 HEALTHCARE, BY SURGICAL METHOD, 2024 TO 2035 (USD Billion) |
    114. 6.111 HEALTHCARE, BY TYPE OF HERNIA, 2024 (% SHARE) |
    115. 6.112 HEALTHCARE, BY TYPE OF HERNIA, 2024 TO 2035 (USD Billion) |
    116. 6.113 HEALTHCARE, BY MATERIAL USED, 2024 (% SHARE) |
    117. 6.114 HEALTHCARE, BY MATERIAL USED, 2024 TO 2035 (USD Billion) |
    118. 6.115 HEALTHCARE, BY END-USE, 2024 (% SHARE) |
    119. 6.116 HEALTHCARE, BY END-USE, 2024 TO 2035 (USD Billion) |
    120. 6.117 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    121. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    122. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY SURGICAL METHOD, 2025-2035 (USD Billion) | |
      2. 7.2.2 BY TYPE OF HERNIA, 2025-2035 (USD Billion) | |
      3. 7.2.3 BY MATERIAL USED, 2025-2035 (USD Billion) | |
      4. 7.2.4 BY END-USE, 2025-2035 (USD Billion) |
    123. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.3.1 BY SURGICAL METHOD, 2025-2035 (USD Billion) | |
      2. 7.3.2 BY TYPE OF HERNIA, 2025-2035 (USD Billion) | |
      3. 7.3.3 BY MATERIAL USED, 2025-2035 (USD Billion) | |
      4. 7.3.4 BY END-USE, 2025-2035 (USD Billion) |
    124. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.4.1 BY SURGICAL METHOD, 2025-2035 (USD Billion) | |
      2. 7.4.2 BY TYPE OF HERNIA, 2025-2035 (USD Billion) | |
      3. 7.4.3 BY MATERIAL USED, 2025-2035 (USD Billion) | |
      4. 7.4.4 BY END-USE, 2025-2035 (USD Billion) |
    125. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.5.1 BY SURGICAL METHOD, 2025-2035 (USD Billion) | |
      2. 7.5.2 BY TYPE OF HERNIA, 2025-2035 (USD Billion) | |
      3. 7.5.3 BY MATERIAL USED, 2025-2035 (USD Billion) | |
      4. 7.5.4 BY END-USE, 2025-2035 (USD Billion) |
    126. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.6.1 BY SURGICAL METHOD, 2025-2035 (USD Billion) | |
      2. 7.6.2 BY TYPE OF HERNIA, 2025-2035 (USD Billion) | |
      3. 7.6.3 BY MATERIAL USED, 2025-2035 (USD Billion) | |
      4. 7.6.4 BY END-USE, 2025-2035 (USD Billion) |
    127. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.7.1 BY SURGICAL METHOD, 2025-2035 (USD Billion) | |
      2. 7.7.2 BY TYPE OF HERNIA, 2025-2035 (USD Billion) | |
      3. 7.7.3 BY MATERIAL USED, 2025-2035 (USD Billion) | |
      4. 7.7.4 BY END-USE, 2025-2035 (USD Billion) |
    128. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.8.1 BY SURGICAL METHOD, 2025-2035 (USD Billion) | |
      2. 7.8.2 BY TYPE OF HERNIA, 2025-2035 (USD Billion) | |
      3. 7.8.3 BY MATERIAL USED, 2025-2035 (USD Billion) | |
      4. 7.8.4 BY END-USE, 2025-2035 (USD Billion) |
    129. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.9.1 BY SURGICAL METHOD, 2025-2035 (USD Billion) | |
      2. 7.9.2 BY TYPE OF HERNIA, 2025-2035 (USD Billion) | |
      3. 7.9.3 BY MATERIAL USED, 2025-2035 (USD Billion) | |
      4. 7.9.4 BY END-USE, 2025-2035 (USD Billion) |
    130. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.10.1 BY SURGICAL METHOD, 2025-2035 (USD Billion) | |
      2. 7.10.2 BY TYPE OF HERNIA, 2025-2035 (USD Billion) | |
      3. 7.10.3 BY MATERIAL USED, 2025-2035 (USD Billion) | |
      4. 7.10.4 BY END-USE, 2025-2035 (USD Billion) |
    131. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.11.1 BY SURGICAL METHOD, 2025-2035 (USD Billion) | |
      2. 7.11.2 BY TYPE OF HERNIA, 2025-2035 (USD Billion) | |
      3. 7.11.3 BY MATERIAL USED, 2025-2035 (USD Billion) | |
      4. 7.11.4 BY END-USE, 2025-2035 (USD Billion) |
    132. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.12.1 BY SURGICAL METHOD, 2025-2035 (USD Billion) | |
      2. 7.12.2 BY TYPE OF HERNIA, 2025-2035 (USD Billion) | |
      3. 7.12.3 BY MATERIAL USED, 2025-2035 (USD Billion) | |
      4. 7.12.4 BY END-USE, 2025-2035 (USD Billion) |
    133. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.13.1 BY SURGICAL METHOD, 2025-2035 (USD Billion) | |
      2. 7.13.2 BY TYPE OF HERNIA, 2025-2035 (USD Billion) | |
      3. 7.13.3 BY MATERIAL USED, 2025-2035 (USD Billion) | |
      4. 7.13.4 BY END-USE, 2025-2035 (USD Billion) |
    134. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.14.1 BY SURGICAL METHOD, 2025-2035 (USD Billion) | |
      2. 7.14.2 BY TYPE OF HERNIA, 2025-2035 (USD Billion) | |
      3. 7.14.3 BY MATERIAL USED, 2025-2035 (USD Billion) | |
      4. 7.14.4 BY END-USE, 2025-2035 (USD Billion) |
    135. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.15.1 BY SURGICAL METHOD, 2025-2035 (USD Billion) | |
      2. 7.15.2 BY TYPE OF HERNIA, 2025-2035 (USD Billion) | |
      3. 7.15.3 BY MATERIAL USED, 2025-2035 (USD Billion) | |
      4. 7.15.4 BY END-USE, 2025-2035 (USD Billion) |
    136. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.16.1 BY SURGICAL METHOD, 2025-2035 (USD Billion) | |
      2. 7.16.2 BY TYPE OF HERNIA, 2025-2035 (USD Billion) | |
      3. 7.16.3 BY MATERIAL USED, 2025-2035 (USD Billion) | |
      4. 7.16.4 BY END-USE, 2025-2035 (USD Billion) |
    137. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.17.1 BY SURGICAL METHOD, 2025-2035 (USD Billion) | |
      2. 7.17.2 BY TYPE OF HERNIA, 2025-2035 (USD Billion) | |
      3. 7.17.3 BY MATERIAL USED, 2025-2035 (USD Billion) | |
      4. 7.17.4 BY END-USE, 2025-2035 (USD Billion) |
    138. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.18.1 BY SURGICAL METHOD, 2025-2035 (USD Billion) | |
      2. 7.18.2 BY TYPE OF HERNIA, 2025-2035 (USD Billion) | |
      3. 7.18.3 BY MATERIAL USED, 2025-2035 (USD Billion) | |
      4. 7.18.4 BY END-USE, 2025-2035 (USD Billion) |
    139. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.19.1 BY SURGICAL METHOD, 2025-2035 (USD Billion) | |
      2. 7.19.2 BY TYPE OF HERNIA, 2025-2035 (USD Billion) | |
      3. 7.19.3 BY MATERIAL USED, 2025-2035 (USD Billion) | |
      4. 7.19.4 BY END-USE, 2025-2035 (USD Billion) |
    140. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.20.1 BY SURGICAL METHOD, 2025-2035 (USD Billion) | |
      2. 7.20.2 BY TYPE OF HERNIA, 2025-2035 (USD Billion) | |
      3. 7.20.3 BY MATERIAL USED, 2025-2035 (USD Billion) | |
      4. 7.20.4 BY END-USE, 2025-2035 (USD Billion) |
    141. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.21.1 BY SURGICAL METHOD, 2025-2035 (USD Billion) | |
      2. 7.21.2 BY TYPE OF HERNIA, 2025-2035 (USD Billion) | |
      3. 7.21.3 BY MATERIAL USED, 2025-2035 (USD Billion) | |
      4. 7.21.4 BY END-USE, 2025-2035 (USD Billion) |
    142. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.22.1 BY SURGICAL METHOD, 2025-2035 (USD Billion) | |
      2. 7.22.2 BY TYPE OF HERNIA, 2025-2035 (USD Billion) | |
      3. 7.22.3 BY MATERIAL USED, 2025-2035 (USD Billion) | |
      4. 7.22.4 BY END-USE, 2025-2035 (USD Billion) |
    143. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.23.1 BY SURGICAL METHOD, 2025-2035 (USD Billion) | |
      2. 7.23.2 BY TYPE OF HERNIA, 2025-2035 (USD Billion) | |
      3. 7.23.3 BY MATERIAL USED, 2025-2035 (USD Billion) | |
      4. 7.23.4 BY END-USE, 2025-2035 (USD Billion) |
    144. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.24.1 BY SURGICAL METHOD, 2025-2035 (USD Billion) | |
      2. 7.24.2 BY TYPE OF HERNIA, 2025-2035 (USD Billion) | |
      3. 7.24.3 BY MATERIAL USED, 2025-2035 (USD Billion) | |
      4. 7.24.4 BY END-USE, 2025-2035 (USD Billion) |
    145. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.25.1 BY SURGICAL METHOD, 2025-2035 (USD Billion) | |
      2. 7.25.2 BY TYPE OF HERNIA, 2025-2035 (USD Billion) | |
      3. 7.25.3 BY MATERIAL USED, 2025-2035 (USD Billion) | |
      4. 7.25.4 BY END-USE, 2025-2035 (USD Billion) |
    146. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.26.1 BY SURGICAL METHOD, 2025-2035 (USD Billion) | |
      2. 7.26.2 BY TYPE OF HERNIA, 2025-2035 (USD Billion) | |
      3. 7.26.3 BY MATERIAL USED, 2025-2035 (USD Billion) | |
      4. 7.26.4 BY END-USE, 2025-2035 (USD Billion) |
    147. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.27.1 BY SURGICAL METHOD, 2025-2035 (USD Billion) | |
      2. 7.27.2 BY TYPE OF HERNIA, 2025-2035 (USD Billion) | |
      3. 7.27.3 BY MATERIAL USED, 2025-2035 (USD Billion) | |
      4. 7.27.4 BY END-USE, 2025-2035 (USD Billion) |
    148. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.28.1 BY SURGICAL METHOD, 2025-2035 (USD Billion) | |
      2. 7.28.2 BY TYPE OF HERNIA, 2025-2035 (USD Billion) | |
      3. 7.28.3 BY MATERIAL USED, 2025-2035 (USD Billion) | |
      4. 7.28.4 BY END-USE, 2025-2035 (USD Billion) |
    149. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.29.1 BY SURGICAL METHOD, 2025-2035 (USD Billion) | |
      2. 7.29.2 BY TYPE OF HERNIA, 2025-2035 (USD Billion) | |
      3. 7.29.3 BY MATERIAL USED, 2025-2035 (USD Billion) | |
      4. 7.29.4 BY END-USE, 2025-2035 (USD Billion) |
    150. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.30.1 BY SURGICAL METHOD, 2025-2035 (USD Billion) | |
      2. 7.30.2 BY TYPE OF HERNIA, 2025-2035 (USD Billion) | |
      3. 7.30.3 BY MATERIAL USED, 2025-2035 (USD Billion) | |
      4. 7.30.4 BY END-USE, 2025-2035 (USD Billion) |
    151. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.31.1 |
    152. 7.32 ACQUISITION/PARTNERSHIP | |

Healthcare Market Segmentation

Healthcare By Surgical Method (USD Billion, 2025-2035)

  • Open Surgery
  • Laparoscopic Surgery
  • Robotic-Assisted Surgery

Healthcare By Type of Hernia (USD Billion, 2025-2035)

  • Direct Inguinal Hernia
  • Indirect Inguinal Hernia

Healthcare By Material Used (USD Billion, 2025-2035)

  • Synthetic Mesh
  • Biological Mesh
  • Absorbable Mesh

Healthcare By End-Use (USD Billion, 2025-2035)

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions